Growth in the Pharmaceutical Industry Shifting from the Developed to the Emerging Markets

Printer-friendly versionPDF version

Future growth in the developed pharmaceutical markets is expected to be buffeted by a massive wave of patent expirations coupled by numerous cost constraining measures.

Delhi, India., February 14, 2013 - (PressReleasePoint) -


The world market for prescription pharmaceuticals will grow at a CAGR of 5% exceeding revenues worth USD 1.1 trillion by 2017, according to a new report titled “Global Pharmaceutical Market Report & Forecast: 2012-2017”. The report which has done a comprehensive analysis on the global pharmaceutical industry expects this market to undergo a number of transitions which would impact the course of its growth.
 
The report expects the developed markets (United States, Western Europe and Japan) to remain the largest and the key markets for medicine manufacturers. The total share of these markets in the overall global market, however, is expected to decline in the coming years. According to an analyst at IMARC Group, “although, the United States and other developed markets will continue to spend a significantly higher per capita on pharmaceuticals than other regions, future growth in these markets is expected to be buffeted by a massive wave of patent expirations coupled by numerous cost constraining measures. In the emerging markets, on the contrary, per-capita incomes are rapidly increasing. With increasing per capita incomes, the total spending on pharmaceuticals is also increasing. With emerging markets accounting for 45-50% of the global population, even a marginal increase in the per capita spending on pharmaceuticals represents a huge opportunity for medicine manufacturers”. Apart from the shift of growth from the developed to the emerging markets, the report expects a number of other transitions which include - increasing focus on biopharmaceuticals compared to small molecule medicine, an increasing preference for generics compared to their branded versions, an increasing focus on personalized medicine rather than blockbuster medicine, etc.
 
IMARC Group, one of the world’s leading research and advisory firms, introduces a new and revolutionary way to understand and evaluate the global pharmaceutical market with its Microsoft Excel based report entitled “Global Pharmaceutical Market Report & Forecast: 2012-2017”. This report provides an analytical and statistical insight into the global pharmaceutical market. The study, which has been undertaken using desk based as well as primary market research, has analyzed the following aspects of the global pharmaceutical market.
 


To buy the complete report or to get a free sample, please contact:
 
IMARC Group Asia
Email: apac@imarcgroup.com
Phone: +91-120-425-6531
 
IMARC Group North America
Email:  america@imarcgroup.com
Phone: +1-631-791-1145
 
IMARC Group Europe, Middle East & Africa
Email:ema@imarcgroup.com
Phone: +44-702-409-7331
 
To know more please visit: http://www.imarcgroup.com/global-biopharmaceutica-market-report-forecasts-2012-2017/